Drug/Insect/Latex News

ORLANDO — Delabeling inappropriate penicillin allergy labels in outpatient pediatric patients is feasible, according to an abstract presented at the American Academy of Pediatrics National Conference & Exhibition.

BOSTON — Physicians suspect the solvent used in the administration of pembrolizumab may have triggered recurrent angioedema for a patient with squamous cell carcinoma, according to a poster presented at the CHEST Annual Meeting.

Healio has compiled October’s most read news in asthma and allergy.

BOSTON — Low-risk patients with syphilis and a penicillin allergy label should be delabeled to avoid treatment failure, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Physicians should consider delayed hypersensitivity reactions such as serum sickness when patients experience symptoms during biologic treatment, according to a poster presented at the CHEST Annual Meeting.

ALK announced the FDA approval of its new line of allergy skin testing devices and well trays, according to a company press release.

BOSTON — Approximately 17% of patients who were admitted to the hospital after a bee sting required mechanical ventilation, according to a study presented at the CHEST Annual Meeting.

A three-session rush venom immunotherapy protocol was safe and effective with nearly all patients achieving maintenance dosing with few systemic reactions, according to a study published in Annals of Allergy, Asthma & Immunology.

Despite daily vigilance in managing food allergies, everything does not always go according to plan.